Correlation Between Lyra Therapeutics and HUTCHMED DRC

Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lyra Therapeutics and HUTCHMED DRC, you can compare the effects of market volatilities on Lyra Therapeutics and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and HUTCHMED DRC.

Diversification Opportunities for Lyra Therapeutics and HUTCHMED DRC

0.52

Correlation Coefficient

Lyra Therapeutics  HUTCHMED DRC

Very weak diversification

The 3 months correlation between Lyra and HUTCHMED is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and HUTCHMED DRC go up and down completely randomly.

Pair Corralation between Lyra Therapeutics and HUTCHMED DRC

Given the investment horizon of 90 days Lyra Therapeutics is expected to generate 1.62 times more return on investment than HUTCHMED DRC. However, Lyra Therapeutics is 1.62 times more volatile than HUTCHMED DRC. It trades about -0.03 of its potential returns per unit of risk. HUTCHMED DRC is currently generating about -0.3 per unit of risk. If you would invest  19.00  in Lyra Therapeutics on September 23, 2024 and sell it today you would lose (1.00) from holding Lyra Therapeutics or give up 5.26% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Lyra Therapeutics  vs.  HUTCHMED DRC

Lyra Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lyra Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

HUTCHMED DRC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days HUTCHMED DRC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Lyra Therapeutics and HUTCHMED DRC

The main advantage of trading using opposite Lyra Therapeutics and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.

The idea behind Lyra Therapeutics and HUTCHMED DRC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..